AYTU vs. ORMP
AYTU (Aytu BioPharma, Inc.) and ORMP (Oramed Pharmaceuticals Inc.) are both stocks. Both are in the Healthcare sector — AYTU in Drug Manufacturers - Specialty & Generic, ORMP in Biotechnology. Over the past 5 years, AYTU returned -51.06%/yr vs -21.00%/yr for ORMP. Their 0.11 correlation means their historical movements had little consistent relationship.
Performance
AYTU vs. ORMP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AYTU achieves a -14.23% return, which is significantly lower than ORMP's 53.19% return.
AYTU
- 1D
- 3.72%
- 1M
- 3.24%
- 6M
- -14.23%
- YTD
- -14.23%
- 1Y
- -7.08%
- 3Y*
- 7.01%
- 5Y*
- -51.06%
- 10Y*
- —
- ALL TIME*
- -67.05%
ORMP
- 1D
- -1.21%
- 1M
- -11.52%
- 6M
- 20.77%
- YTD
- 53.19%
- 1Y
- 105.93%
- 3Y*
- 9.67%
- 5Y*
- -21.00%
- 10Y*
- -5.95%
- ALL TIME*
- -4.37%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $55.01K | $54.55K | $81.73K | |
| $602.28K | $784.57K | $1.29M |
AYTU vs. ORMP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AYTU Aytu BioPharma, Inc. | -14.23% | 52.94% | -40.14% | -24.87% | -86.00% | -77.42% | -38.35% | 22.41% | -98.22% | -89.38% |
ORMP Oramed Pharmaceuticals Inc. | 53.19% | 17.77% | 4.76% | -80.80% | -15.76% | 236.79% | -17.67% | 71.67% | -66.67% | 37.40% |
Correlation
The correlation between AYTU and ORMP is 0.13, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.13 |
Correlation (3Y) Balances recent behavior with more history. | 0.10 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.18 |
Correlation (All Time) Calculated using the full available price history since Feb 1, 2017 | 0.11 |
Fundamentals
AYTU:
$23.94M
ORMP:
$166.57M
AYTU:
-$2.55
ORMP:
$2.86
AYTU:
0.67
ORMP:
0.72
AYTU:
$56.60M
ORMP:
$0.00
AYTU:
$36.14M
ORMP:
$0.00
AYTU:
-$27.34M
ORMP:
$67.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AYTU vs. ORMP — Risk / Return Rank
AYTU
ORMP
AYTU vs. ORMP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Aytu BioPharma, Inc. (AYTU) and Oramed Pharmaceuticals Inc. (ORMP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AYTU | ORMP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.08 | ||
| Sortino ratioReturn per unit of downside risk | -2.58 | ||
| Omega ratioGain probability vs. loss probability | 1.02 | 1.33 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | -0.24 | 4.34 | -4.58 |
| Martin ratioReturn relative to average drawdown | -0.49 | 10.18 | -10.67 |
Loading charts...
Drawdowns
AYTU vs. ORMP - Drawdown Comparison
The maximum AYTU drawdown since its inception was -100.00%, which is greater than ORMP's maximum drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for AYTU and ORMP.
Loading charts...
Drawdown Indicators
| AYTU | ORMP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -94.25% | -5.75% |
Max Drawdown (1Y)Largest decline over 1 year | -35.47% | -23.89% | -11.58% |
Max Drawdown (3Y)Largest decline over 3 years | -70.24% | -50.29% | -19.95% |
Max Drawdown (5Y)Largest decline over 5 years | -98.74% | -94.25% | -4.49% |
Max Drawdown (10Y)Largest decline over 10 years | — | -94.25% | — |
Current DrawdownCurrent decline from peak | -100.00% | -85.33% | -14.67% |
Average DrawdownAverage peak-to-trough decline | -95.33% | -70.85% | -24.48% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.59% | 10.17% | +7.42% |
Volatility
AYTU vs. ORMP - Volatility Comparison
The current volatility for Aytu BioPharma, Inc. (AYTU) is 10.72%, while Oramed Pharmaceuticals Inc. (ORMP) has a volatility of 11.91%. This indicates that AYTU experiences smaller price fluctuations and is considered to be less risky than ORMP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AYTU | ORMP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.72% | 11.91% | -1.19% |
Volatility (6M)Calculated over the trailing 6-month period | 31.58% | 40.10% | -8.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 54.31% | 54.09% | +0.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.24% | 80.52% | +4.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 186.78% | 72.22% | +114.56% |
Dividends
AYTU vs. ORMP - Dividend Comparison
AYTU has not paid dividends to shareholders, while ORMP's dividend yield for the trailing twelve months is around 6.14%.
| Position | TTM |
|---|---|
AYTU Aytu BioPharma, Inc. | 0.00% |
ORMP Oramed Pharmaceuticals Inc. | 6.14% |
Financials
AYTU vs. ORMP - Financials Comparison
This section allows you to compare key financial metrics between Aytu BioPharma, Inc. and Oramed Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AYTU and ORMP have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ORMP has higher volatility (11.91%) compared to AYTU (10.72%). In terms of maximum drawdown, AYTU dropped -100.00% vs ORMP's -94.25%.
ORMP currently has the higher Sharpe Ratio (1.92 vs -0.16), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AYTU and ORMP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer